Ascendis says it has completed the acquisition of Romanian-based Sunwave Pharma for €16.35m and Cyprus’s NHP Natural Health Pharma for between €26.1m and €49.1m. The final price for NHP Pharma depends on the financial performance of the business over the next three years. The company said the new acquisitions provided an attractive platform for Ascendis’ entry into the Romanian over-the-counter market, which aligned with its strategy of focusing on Central and Eastern Europe. It would also provide access to a vast portfolio of complementary medicines and a pipeline of new products that could be sold in territories in which Ascendis was active. Sunwave distributes complementary and alternative medicines and food supplement products in Romania. NHP Pharma in collaboration with third-party suppliers, has developed a product portfolio of complementary medicines across nine major therapeutic areas. The Sunwave Pharma and NHP Pharma acquisitions follow that of Cyprus-based pharmaceutical ...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.